Digital Edition

Abstracts Presented at the 2019 AVAHO Annual Meeting

September 20-22, 2019 ► Minneapolis, MI

Fed Pract. 2019 August;36(suppl)

 

Table of Contents

Recommended Reading

Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man (FULL)
AVAHO
SC daratumumab deemed feasible for every multiple myeloma patient
AVAHO
Gaps in patient-provider survivorship communication persist
AVAHO
Ibrutinib-venetoclax found highly active in hard-to-treat CLL
AVAHO
BRCA2 mutations linked to childhood NHL
AVAHO
Cancer survivors face more age-related deficits
AVAHO
Ibrutinib-rituximab induction yields ‘unprecedented’ responses in MCL
AVAHO
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation in a Veteran Population
AVAHO
Investigation of Outpatient Infusion Space Utilization to Increase Access to Same-Day Transfusion for Hematology/Oncology Patients
AVAHO
Standardization of the Discharge Process for Inpatient Hematology and Oncology
AVAHO